We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+21.5%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.75B
AUM Growth
+$332M
Cap. Flow
-$28.9M
Cap. Flow %
-0.5%
Top 10 Hldgs %
51.71%
Holding
444
New
223
Increased
65
Reduced
45
Closed
77

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$54.6M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$40.8M
3
SGRY icon
Surgery Partners
SGRY
+$33.8M
4
LRMR icon
Larimar Therapeutics
LRMR
+$33.4M
5
ALHC icon
Alignment Healthcare
ALHC
+$30.6M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$62.6M
2
SWTX
SpringWorks Therapeutics
SWTX
+$60.2M
3
BAX icon
Baxter International
BAX
+$55M
4
VKTX icon
Viking Therapeutics
VKTX
+$36.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.87%
2 Industrials 0.71%
3 Technology 0.31%
4 Consumer Discretionary 0.26%
5 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGEE icon
401
MGE Energy Inc
MGEE
$3.03B
– –
-2,856
Closed -$207K
MIR icon
402
Mirion Technologies
MIR
$3.63B
– –
-16,404
Closed -$168K
MLAB icon
403
Mesa Laboratories
MLAB
$551M
– –
-4,313
Closed -$452K
MPC icon
404
Marathon Petroleum
MPC
$90.1B
– –
-1,632
Closed -$242K
MRK icon
405
Merck
MRK
$322B
– –
-2,960
Closed -$323K
MUR icon
406
Murphy Oil
MUR
$5.55B
– –
-11,625
Closed -$496K
MXCT icon
407
MaxCyte
MXCT
$108M
– –
-50,031
Closed -$235K
NOVA
408
DELISTED
Sunnova Energy
NOVA
– –
-11,271
Closed -$172K
NUE icon
409
Nucor
NUE
$58.3B
– –
-1,545
Closed -$269K
NYXH
410
Nyxoah
NYXH
$139M
– –
-174,842
Closed -$811K
ONTF
411
DELISTED
ON24
ONTF
– –
-30,009
Closed -$236K
OPI
412
DELISTED
Office Properties Income Trust
OPI
– –
-15,718
Closed -$115K
OPK icon
413
Opko Health
OPK
$1.02B
– –
-80,348
Closed -$121K
PLUG icon
414
Plug Power
PLUG
$2.65B
– –
-27,848
Closed -$125K
PNW icon
415
Pinnacle West Capital
PNW
$12.4B
– –
-3,512
Closed -$252K
PPC icon
416
Pilgrim's Pride
PPC
$7.13B
– –
-19,960
Closed -$552K
RMD icon
417
ResMed
RMD
$31.1B
– –
-1,439
Closed -$248K
RNAM
418
DELISTED
Avidity Biosciences
RNAM
– –
-18,708
Closed -$169K
SAH icon
419
Sonic Automotive
SAH
$3.56B
– –
-4,896
Closed -$275K
SANA icon
420
Sana Biotechnology
SANA
$882M
– –
-12,530
Closed -$51.1K
SMP icon
421
Standard Motor Products
SMP
$902M
– –
-9,754
Closed -$388K
SVC
422
Service Properties Trust
SVC
$1.05B
– –
-5,854
Closed -$250K
TGT icon
423
Target
TGT
$66.3B
– –
-2,024
Closed -$288K
TRS icon
424
TriMas Corp
TRS
$1.41B
– –
-21,896
Closed -$555K
UNM icon
425
Unum
UNM
$13.2B
– –
-5,333
Closed -$241K
14 15 16
17
18

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2024 Portfolio in Review

As of Q1 2024, Deerfield Management held 444 positions worth $5.75B, up 6.1% from $5.42B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q1 2024 filing shows 223 new, 65 increased, 45 reduced and 77 closed positions. Its largest new stake was BioNTech: 569,574 shares worth $52.5M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $62.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 78% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q1 2024 buy was BioNTech: 569,574 shares worth $52.5M.
  • Deerfield Management added most to Surgery Partners in Q1 2024, an estimated $33.8M increase.
  • Deerfield Management's biggest Q1 2024 reduction was SpringWorks Therapeutics, cutting an estimated $60.2M.
  • Deerfield Management fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $62.6M.
  • Deerfield Management's ten largest holdings make up 52% of its $5.75B portfolio in Q1 2024.
  • Deerfield Management opened 223 new positions and closed 77 in Q1 2024.
  • Deerfield Management's portfolio value rose 6.1% quarter-over-quarter to $5.75B.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.